HOME >> BIOLOGY >> NEWS
Heat kills inoperable liver tumors without initiating onslaught of harmful hormones

By Melanie Fridl Ross

Gainesville, FL --- The hottest new weapon in the surgeon's arsenal against liver cancer uses heat instead of cold, a shift that could put the freeze on what until now has been the standard therapy for inoperable tumors. What's more, it's easy, cheap and considerably less risky to perform than surgery or using cold to zap malignancies.

Now University of Florida researchers have found that the technique, known as radiofrequency ablation, does not initiate a cascade of harmful hormones that often causes patients who undergo the alternative -- cryotherapy -- to go into shock. Surgeons are scheduled to report the new findings Saturday (2/3) at the annual scientific meeting of the Southeastern Surgical Congress in New Orleans.

"An unfortunate byproduct of cryotherapy is people will develop a form of shock related to the treatment, which has to do with the fact that circulating hormone levels in the body increase and cause a bad systemic reaction, similar to massive overwhelming infection," said Dr. Scott Schell an assistant professor of surgery and of molecular genetics and microbiology at UF's College of Medicine and the UF Shands Cancer Center.

Last summer, the Food and Drug Administration approved the use of radiofrequency ablation, traditionally used to correct heart arrhythmias, for the treatment of liver tumors. For terminally ill liver cancer patients with no other options, the approach offers an alternative that helps slow the disease process, improving their quality of life, Schell said.

"These are patients who basically have no other hope," Schell said. "We are able to help set back the clock using radiofrequency ablation."

Of the estimated 150,000 patients who will be treated for colorectal cancer this year, about half will suffer a recurrence within five years. Less than a third of those people will respond to chemotherapy, and of the tumors that return, most spread to the liver. Chemotherapy doe
'"/>

Contact: Jennifer Guyan
jguyan@vpha.health.ufl.edu
352-392-2621
University of Florida
31-Jan-2001


Page: 1 2 3

Related biology news :

1. An exotic grass kills trees by hijacking their water
2. Cinnamon oil kills mosquitoes
3. Birds show superior listening skills
4. New designed paclitaxel analog kills more cancer cells than natural product
5. UNC study finds protein in male reproductive tract kills bacteria, may improve fertility
6. Fishing kills Fijian coral reefs
7. New paclitaxel analog kills more cancer cells than natural product
8. Toxin combo common in fish appears capable of impairing motor skills
9. Researchers-again-pinpoint why stress kills
10. Technique kills cancerous cells, leaves healthy cells intact
11. New research finds garlic kills slugs

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/24/2016)... -- Cercacor today introduced Ember TM Sport Premium ... measure hemoglobin, Oxygen Content, Oxygen Saturation, Perfusion Index, ... approximately 30 seconds. Smaller than a smartphone, using only ... key data about their bodies to help monitor these ... Hemoglobin carries oxygen to muscles. When hemoglobin and ...
(Date:11/19/2016)... Securus Technologies, a leading provider of civil and criminal ... monitoring, announced today that it has offered a challenge ... technology judge determine who has the largest and best ... platform, and the best customer service. "ICSolutions ... we do – which clearly is not the case ...
(Date:11/15/2016)... ROCKVILLE, Md. , Nov. 15, 2016 /PRNewswire/ ... clinical company developing therapeutics focused on the gut ... public offering of 25,000,000 shares of its common ... its common stock at a price to the ... gross proceeds to Synthetic Biologics from the offering, ...
Breaking Biology News(10 mins):
(Date:12/5/2016)... 2016 Research and Markets has announced ... Markets and Companies" to their offering. ... , , ... various -omics technologies such as proteomics and metabolomics. Molecular diagnostics technologies ... also based on biomarker. Currently the most important applications ...
(Date:12/5/2016)... 2016 According to the ... Products (Consumable, Instruments, Automated Cell Expansion System), Cells ... Cell Research, Cancer, and Cell-Based Research), End-users (Biopharmaceutical ... Global Revenue, Trends, Growth, Share, Size and Forecast ... global cell expansion market is expected to reach ...
(Date:12/5/2016)... RAPIDS, Mich. , Dec. 5, 2016 NxGen MDx announced ... "By bringing the test in house, we,ve been able to improve customer ... down for patients," says Alan Mack , CEO of NxGen MDx. ... , , ... in test volume has led to more job opportunities at the Grand ...
(Date:12/5/2016)... YORK , December 5, 2016 ... player worldwide, with almost $108 billion of revenue and ... $170 billion were spent on global biopharmaceuticals, and this ... This morning, Stock-Callers.com has lined up these four equities ... ), ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD ), ...
Breaking Biology Technology:
Cached News: